Familial hemophagocytic lymphohistiocytosis: When rare diseases shed light on immune system functioning

Elena Sieni, Valentina Cetica, Yvonne Hackmann, Maria Luisa Coniglio, Martina Da Ros, Benedetta Ciambotti, Daniela Pende, Gillian Griffiths, Maurizio Aricò

Research output: Contribution to journalArticle

Abstract

The human immune system depends on the activity of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and NKT cells in order to fight off a viral infection. Understanding the molecular mechanisms during this process and the role of individual proteins was greatly improved by the study of familial hemophagocytic lymphohistiocytosis (FHL). Since 1999, genetic sequencing is the gold standard to classify patients into different subgroups of FHL. The diagnosis, once based on a clinical constellation of abnormalities, is now strongly supported by the results of a functional flow-cytometry screening, which directs the genetic study. A few additional congenital immune deficiencies can also cause a resembling or even identical clinical picture to FHL. As in many other rare human disorders, the collection and analysis of a relatively large number of cases in registries is crucial to draw a complete picture of the disease. The conduction of prospective therapeutic trials allows investigators to increase the awareness of the disease and to speed up the diagnostic process, but also provides important functional and genetic confirmations. Children with confirmed diagnosis may undergo hematopoietic stem cell transplantation, which is the only cure known to date. Moreover, detailed characterization of these rare patients helped to understand the function of individual proteins within the exocytic machinery of CTL, NK, and NKT cells. Moreover, identification of these genotypes also provides valuable information on variant phenotypes, other than FHL, associated with biallelic and monoallelic mutations in the FHL-related genes. In this review, we describe how detailed characterization of patients with genetic hemophagocytic lymphohistiocytosis has resulted in improvement in knowledge regarding contribution of individual proteins to the functional machinery of cytotoxic T- and NK-cells. The review also details how identification of these genotypes has provided valuable information on variant phenotypes.

Original languageEnglish
Article numberArticle 167
JournalFrontiers in Immunology
Volume5
Issue numberAPR
DOIs
Publication statusPublished - 2014

Fingerprint

Hemophagocytic Lymphohistiocytosis
Rare Diseases
Immune System
Natural Killer T-Cells
Cytotoxic T-Lymphocytes
Natural Killer Cells
Genotype
Phenotype
Proteins
Hematopoietic Stem Cell Transplantation
Virus Diseases
Registries
Flow Cytometry
Research Personnel
Mutation
Genes

Keywords

  • Cellular cytotoxicity
  • Hemophagocytosis
  • Mutation analysis
  • Natural killer

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Sieni, E., Cetica, V., Hackmann, Y., Coniglio, M. L., Da Ros, M., Ciambotti, B., ... Aricò, M. (2014). Familial hemophagocytic lymphohistiocytosis: When rare diseases shed light on immune system functioning. Frontiers in Immunology, 5(APR), [Article 167]. https://doi.org/10.3389/fimmu.2014.00167

Familial hemophagocytic lymphohistiocytosis : When rare diseases shed light on immune system functioning. / Sieni, Elena; Cetica, Valentina; Hackmann, Yvonne; Coniglio, Maria Luisa; Da Ros, Martina; Ciambotti, Benedetta; Pende, Daniela; Griffiths, Gillian; Aricò, Maurizio.

In: Frontiers in Immunology, Vol. 5, No. APR, Article 167, 2014.

Research output: Contribution to journalArticle

Sieni, E, Cetica, V, Hackmann, Y, Coniglio, ML, Da Ros, M, Ciambotti, B, Pende, D, Griffiths, G & Aricò, M 2014, 'Familial hemophagocytic lymphohistiocytosis: When rare diseases shed light on immune system functioning', Frontiers in Immunology, vol. 5, no. APR, Article 167. https://doi.org/10.3389/fimmu.2014.00167
Sieni, Elena ; Cetica, Valentina ; Hackmann, Yvonne ; Coniglio, Maria Luisa ; Da Ros, Martina ; Ciambotti, Benedetta ; Pende, Daniela ; Griffiths, Gillian ; Aricò, Maurizio. / Familial hemophagocytic lymphohistiocytosis : When rare diseases shed light on immune system functioning. In: Frontiers in Immunology. 2014 ; Vol. 5, No. APR.
@article{d4b4572dc6294c1b8e411e5cad48362a,
title = "Familial hemophagocytic lymphohistiocytosis: When rare diseases shed light on immune system functioning",
abstract = "The human immune system depends on the activity of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and NKT cells in order to fight off a viral infection. Understanding the molecular mechanisms during this process and the role of individual proteins was greatly improved by the study of familial hemophagocytic lymphohistiocytosis (FHL). Since 1999, genetic sequencing is the gold standard to classify patients into different subgroups of FHL. The diagnosis, once based on a clinical constellation of abnormalities, is now strongly supported by the results of a functional flow-cytometry screening, which directs the genetic study. A few additional congenital immune deficiencies can also cause a resembling or even identical clinical picture to FHL. As in many other rare human disorders, the collection and analysis of a relatively large number of cases in registries is crucial to draw a complete picture of the disease. The conduction of prospective therapeutic trials allows investigators to increase the awareness of the disease and to speed up the diagnostic process, but also provides important functional and genetic confirmations. Children with confirmed diagnosis may undergo hematopoietic stem cell transplantation, which is the only cure known to date. Moreover, detailed characterization of these rare patients helped to understand the function of individual proteins within the exocytic machinery of CTL, NK, and NKT cells. Moreover, identification of these genotypes also provides valuable information on variant phenotypes, other than FHL, associated with biallelic and monoallelic mutations in the FHL-related genes. In this review, we describe how detailed characterization of patients with genetic hemophagocytic lymphohistiocytosis has resulted in improvement in knowledge regarding contribution of individual proteins to the functional machinery of cytotoxic T- and NK-cells. The review also details how identification of these genotypes has provided valuable information on variant phenotypes.",
keywords = "Cellular cytotoxicity, Hemophagocytosis, Mutation analysis, Natural killer",
author = "Elena Sieni and Valentina Cetica and Yvonne Hackmann and Coniglio, {Maria Luisa} and {Da Ros}, Martina and Benedetta Ciambotti and Daniela Pende and Gillian Griffiths and Maurizio Aric{\`o}",
year = "2014",
doi = "10.3389/fimmu.2014.00167",
language = "English",
volume = "5",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S.A.",
number = "APR",

}

TY - JOUR

T1 - Familial hemophagocytic lymphohistiocytosis

T2 - When rare diseases shed light on immune system functioning

AU - Sieni, Elena

AU - Cetica, Valentina

AU - Hackmann, Yvonne

AU - Coniglio, Maria Luisa

AU - Da Ros, Martina

AU - Ciambotti, Benedetta

AU - Pende, Daniela

AU - Griffiths, Gillian

AU - Aricò, Maurizio

PY - 2014

Y1 - 2014

N2 - The human immune system depends on the activity of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and NKT cells in order to fight off a viral infection. Understanding the molecular mechanisms during this process and the role of individual proteins was greatly improved by the study of familial hemophagocytic lymphohistiocytosis (FHL). Since 1999, genetic sequencing is the gold standard to classify patients into different subgroups of FHL. The diagnosis, once based on a clinical constellation of abnormalities, is now strongly supported by the results of a functional flow-cytometry screening, which directs the genetic study. A few additional congenital immune deficiencies can also cause a resembling or even identical clinical picture to FHL. As in many other rare human disorders, the collection and analysis of a relatively large number of cases in registries is crucial to draw a complete picture of the disease. The conduction of prospective therapeutic trials allows investigators to increase the awareness of the disease and to speed up the diagnostic process, but also provides important functional and genetic confirmations. Children with confirmed diagnosis may undergo hematopoietic stem cell transplantation, which is the only cure known to date. Moreover, detailed characterization of these rare patients helped to understand the function of individual proteins within the exocytic machinery of CTL, NK, and NKT cells. Moreover, identification of these genotypes also provides valuable information on variant phenotypes, other than FHL, associated with biallelic and monoallelic mutations in the FHL-related genes. In this review, we describe how detailed characterization of patients with genetic hemophagocytic lymphohistiocytosis has resulted in improvement in knowledge regarding contribution of individual proteins to the functional machinery of cytotoxic T- and NK-cells. The review also details how identification of these genotypes has provided valuable information on variant phenotypes.

AB - The human immune system depends on the activity of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and NKT cells in order to fight off a viral infection. Understanding the molecular mechanisms during this process and the role of individual proteins was greatly improved by the study of familial hemophagocytic lymphohistiocytosis (FHL). Since 1999, genetic sequencing is the gold standard to classify patients into different subgroups of FHL. The diagnosis, once based on a clinical constellation of abnormalities, is now strongly supported by the results of a functional flow-cytometry screening, which directs the genetic study. A few additional congenital immune deficiencies can also cause a resembling or even identical clinical picture to FHL. As in many other rare human disorders, the collection and analysis of a relatively large number of cases in registries is crucial to draw a complete picture of the disease. The conduction of prospective therapeutic trials allows investigators to increase the awareness of the disease and to speed up the diagnostic process, but also provides important functional and genetic confirmations. Children with confirmed diagnosis may undergo hematopoietic stem cell transplantation, which is the only cure known to date. Moreover, detailed characterization of these rare patients helped to understand the function of individual proteins within the exocytic machinery of CTL, NK, and NKT cells. Moreover, identification of these genotypes also provides valuable information on variant phenotypes, other than FHL, associated with biallelic and monoallelic mutations in the FHL-related genes. In this review, we describe how detailed characterization of patients with genetic hemophagocytic lymphohistiocytosis has resulted in improvement in knowledge regarding contribution of individual proteins to the functional machinery of cytotoxic T- and NK-cells. The review also details how identification of these genotypes has provided valuable information on variant phenotypes.

KW - Cellular cytotoxicity

KW - Hemophagocytosis

KW - Mutation analysis

KW - Natural killer

UR - http://www.scopus.com/inward/record.url?scp=84900860054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900860054&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2014.00167

DO - 10.3389/fimmu.2014.00167

M3 - Article

AN - SCOPUS:84900860054

VL - 5

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - APR

M1 - Article 167

ER -